Dermatology Drugs Global Market Forecast To 2022

Asia Pacific was the largest region in the global dermatology drugs market, accounting for 36% of the market in 2018. North America was the second largest region accounting for 28% of the global dermatology drugs market. Africa was the smallest region in the global dermatology drugs market.

Pharmaceutical companies are offering new drugs referred to as immune modulators for the treatment of skin diseases such as eczema. Eczema is a chronic skin condition caused by the lack of skin proteins that results in inflammation and irritation in the skin. These drugs are used to externally treat the skin without changing the immune system of the body. In addition, unlike topical steroids, these new medications do not cause thinning of the skin and breaking of superficial blood vessels. Tacrolimus (Protopic) and Pimecrolimus (Elidel) are major drugs available for the treatment of eczema.

Tags: Global Dermatology Drugs Market, Global Dermatology Drugs Market Research Report, Global Dermatology Drugs Market Revenue, Global Dermatology Drugs Market Share